Abingdon Health (LON:ABDX) Posts Earnings Results

Abingdon Health (LON:ABDX) posted its quarterly earnings results on Tuesday. The company reported GBX (0.51) earnings per share for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Trading Up 0.6%

Shares of LON ABDX traded up GBX 0.05 during trading hours on Thursday, hitting GBX 9.05. 571,644 shares of the company traded hands, compared to its average volume of 237,414. The stock has a market capitalization of £22.87 million, a price-to-earnings ratio of -11.17 and a beta of 0.13. The company’s 50 day moving average price is GBX 10.70 and its 200 day moving average price is GBX 10.53. Abingdon Health has a 12 month low of GBX 5.50 and a 12 month high of GBX 13. The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.